The content is available as a PDF (277.9 KB).
letter . 2023 Jun 23. Online ahead of print. doi: 10.1016/j.repc.2023.06.003
Reply to: RAAS inhibitors in COVID-19: not all are created equal!
Resposta a: Inibidores de RAAS no COVID-19: nem todos são iguais!
Jorge Gonçalves
a,b,⁎, Catarina D Santos
a, Paula Fresco
a,b, Fernando Fernandez-Llimos
a,b
Jorge Gonçalves
aLaboratório de Farmacologia, Faculdade de Farmácia, Universidade do Porto, Portugal
bMechanistic Pharmacology and Pharmacotherapy Unit, UCIBIO-i4HB, Faculty of Pharmacy, University of Porto, Porto, Portugal
Find articles by Jorge Gonçalves
Catarina D Santos
aLaboratório de Farmacologia, Faculdade de Farmácia, Universidade do Porto, Portugal
Find articles by Catarina D Santos
Paula Fresco
aLaboratório de Farmacologia, Faculdade de Farmácia, Universidade do Porto, Portugal
bMechanistic Pharmacology and Pharmacotherapy Unit, UCIBIO-i4HB, Faculty of Pharmacy, University of Porto, Porto, Portugal
Find articles by Paula Fresco
Fernando Fernandez-Llimos
aLaboratório de Farmacologia, Faculdade de Farmácia, Universidade do Porto, Portugal
bMechanistic Pharmacology and Pharmacotherapy Unit, UCIBIO-i4HB, Faculty of Pharmacy, University of Porto, Porto, Portugal
Find articles by Fernando Fernandez-Llimos
aLaboratório de Farmacologia, Faculdade de Farmácia, Universidade do Porto, Portugal
bMechanistic Pharmacology and Pharmacotherapy Unit, UCIBIO-i4HB, Faculty of Pharmacy, University of Porto, Porto, Portugal
⁎
Corresponding author
© 2023 Published by Elsevier España, S.L.U. on behalf of Sociedade Portuguesa de Cardiologia.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC10288312 PMID: 37356667